Get started
NEKTAR THERAPEUTICNEKTAR THERAPEUTICNEKTAR THERAPEUTIC

NEKTAR THERAPEUTIC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

NKTR chart


Full chart

NKTR upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪86.40 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.425 CHF
Net income (FY)
‪−108.04 M‬ CHF
Revenue (FY)
‪89.39 M‬ CHF
Shares float
‪11.96 M‬
Beta (1Y)
2.80

Employees


Employees (FY)
61
Change (1Y)
−76 −55.47%
Revenue / Employee (1Y)
‪1.47 M‬ CHF
Net income / Employee (1Y)
‪−1.77 M‬ CHF

About Nektar Therapeutics


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Howard W. Robin
Website
nektar.com
Headquarters
San Francisco
Founded
1990
FIGI
BBG00LVF05P6
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NKTR news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NKTR.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BX exchange NEKTAR THERAPEUTIC stocks are traded under the ticker NKTR.
We've gathered analysts' opinions on NEKTAR THERAPEUTIC future price: according to them, NKTR price has a max estimate of 85.62 CHF and a min estimate of 24.46 CHF. Watch NKTR chart and read a more detailed NEKTAR THERAPEUTIC stock forecast: see what analysts think of NEKTAR THERAPEUTIC and suggest that you do with its stocks.
Yes, you can track NEKTAR THERAPEUTIC financials in yearly and quarterly reports right on TradingView.
NEKTAR THERAPEUTIC is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
NKTR earnings for the last quarter are −3.19 CHF per share, whereas the estimation was −2.27 CHF resulting in a −40.39% surprise. The estimated earnings for the next quarter are −2.41 CHF per share. See more details about NEKTAR THERAPEUTIC earnings.
NEKTAR THERAPEUTIC revenue for the last quarter amounts to ‪9.26 M‬ CHF, despite the estimated figure of ‪13.59 M‬ CHF. In the next quarter, revenue is expected to reach ‪7.69 M‬ CHF.
NKTR net income for the last quarter is ‪−45.04 M‬ CHF, while the quarter before that showed ‪6.59 M‬ CHF of net income which accounts for −783.05% change. Track more NEKTAR THERAPEUTIC financial stats to get the full picture.
No, NKTR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 15, 2025, the company has 61 employees. See our rating of the largest employees — is NEKTAR THERAPEUTIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEKTAR THERAPEUTIC EBITDA is ‪−120.94 M‬ CHF, and current EBITDA margin is −130.78%. See more stats in NEKTAR THERAPEUTIC financial statements.
Like other stocks, NKTR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEKTAR THERAPEUTIC stock right from TradingView charts — choose your broker and connect to your account.